IP Verse

Krka, Tovarna Zdravil, D.d., Novo Mesto competitive analysis

Latest oppositions filed by Krka, Tovarna Zdravil, D.d., Novo Mesto

Explore patent oppositions filed by Krka, Tovarna Zdravil, D.d., Novo Mesto against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP3215130
Pharmaceutical Composition Comprising Bisoprolol And PerindorilLES LABORATOIRES SERVIERApr 8, 2021
EP2797581
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEFeb 5, 2021

Latest patents of Krka, Tovarna Zdravil, D.d., Novo Mesto opposed by its competitors

Explore Krka, Tovarna Zdravil, D.d., Novo Mesto's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2588090
Nov 22, 2023Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts4
EP2585051
Apr 8, 2020Pharmaceutical Oral Dosage Forms Comprising Lercanidipine And Enalapril And Their Pharmaceutically Acceptable Salts1

Latest PTAB cases involving Krka, Tovarna Zdravil, D.d., Novo Mesto

Discover the latest PTAB cases involving Krka, Tovarna Zdravil, D.d., Novo Mesto, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Krka, Tovarna Zdravil, D.d., Novo Mesto with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
KRKA279 - -
EDER3 - - -
GENERICS UK226 - - -
GEORG KALHAMMER/STEPHAN TEIPEL3 - - -